NOBIAS THERAPEUTICS
Live / Registered — Registered (as of 19 Jul 2022)
What this means for you
Registered since 19 Jul 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90708830
- Registration number
- 6799067
- Mark type
- Stylized text
- Filed
- 13 May 2021
- Published for opposition
- 15 Mar 2022
- Registered
- 19 Jul 2022
- Attorney of record
- Carole R. Klein
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for use in the treatment of pediatric genetic disorders; pharmaceutical preparations and substances to actively fight rare, congenital, and potentially life-threatening pediatric diseases
- Class 042 — Scientific and technological services: Pharmaceutical research, drug discovery and drug development services; medical and scientific research in the field of pediatric genetic disorders; research and development of pharmaceutical preparations for the treatment of rare, congenital, and potentially life-threatening pediatric diseases
Owner
- Nobias Therapeutics, Inc., Wayne, PA, US
- Nobias Therapeutics, Inc., Wayne, PA, US
- Nobias Therapeutics, Inc., Wayne, PA, US
Prosecution history
- 19 Jul 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 19 Jul 2022 — REGISTERED-PRINCIPAL REGISTER
- 11 Jun 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Jun 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Jun 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 20 May 2022 — USE AMENDMENT FILED
- 07 Jun 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 20 May 2022 — TEAS STATEMENT OF USE RECEIVED
- 10 May 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 15 Mar 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Mar 2022 — PUBLISHED FOR OPPOSITION
- 23 Feb 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Feb 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 28 Jan 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 27 Jan 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE